Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Characterization of potential predictive biomarkers of response to nivolumab in CheckMate 141 in patients with squamous cell carcinoma of the head and neck (SCCHN). Concha-Benavente, F., Gillison, M. L., Blumenschein, G. R., Harrington, K., Fayette, J., Colevas, A., Licitra, L., Kasper, S., Even, C., Worden, F. P., Saba, N. F., Haddad, R. I., Tahara, M., Hasegawa, Y., Yen, C., Lynch, M., Monga, M., Geese, W. J., Vokes, E. E., Ferris, R. L. AMER SOC CLINICAL ONCOLOGY. 2017
View details for DOI 10.1200/JCO.2017.35.15_suppl.6050
View details for Web of Science ID 000411931705048